ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations

被引:211
作者
Kemp, S
Pujol, A
Waterham, HR
van Geel, BM
Boehm, CD
Raymond, GV
Cutting, GR
Wanders, RJA
Hugo, HW
机构
[1] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands
[4] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, CU Strasbourg, France
[5] Johns Hopkins Univ, Inst Med Genet, Baltimore, MD USA
[6] Kennedy Krieger Inst, Baltimore, MD USA
关键词
ALD; ALDP; Addison disease; ABCD1; database; diagnosis; peroxisomal; fatty acid; transmembrane transporter; ABC; X-linked adrenoleukodystrophy; X-ALD;
D O I
10.1002/humu.1227
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene, which encodes a peroxisomal ABC half-transporter (ALDP) involved in the import of very long-chain fatty acids (VLCFA) into the peroxisome. The disease is characterized by a striking and unpredictable variation in phenotypic expression. Phenotypes include the rapidly progressive childhood cerebral form (CCALD), the milder adult form, adrenomyeloneuropathy (AMN), and variants without neurologic involvement. There is no apparent correlation between genotype and phenotype. In males, unambiguous diagnosis can be achieved by demonstration of elevated levels of VLCFA in plasma. In 15 to 20% of obligate heterozygotes, however, test results are false-negative. Therefore, mutation analysis is the only reliable method for the identification of heterozygotes. Since most X-ALD kindreds have a unique mutation, a great number of mutations have been identified in the ABCD1 gene in the last seven years. In order to catalog and facilitate the analysis of these mutations, we have established a mutation database for X-ALD (http://www.x-ald.nl). In this review we report a detailed analysis of all 406 X-ALD mutations currently included in the database. Also, we present 47 novel mutations. In addition, we review the various X-ALD phenotypes, the different diagnostic tools, and the need for extended family screening for the identification of new patients. Hum Mutat 18:499-515, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:499 / 515
页数:17
相关论文
共 88 条
[51]   THE GENE RESPONSIBLE FOR ADRENOLEUKODYSTROPHY ENCODES A PEROXISOMAL MEMBRANE-PROTEIN [J].
MOSSER, J ;
LUTZ, Y ;
STOECKEL, ME ;
SARDE, CO ;
KRETZ, C ;
DOUAR, AM ;
LOPEZ, J ;
AUBOURG, P ;
MANDEL, JL .
HUMAN MOLECULAR GENETICS, 1994, 3 (02) :265-271
[52]   CHILDHOOD ADRENOLEUKODYSTROPHY - FAILURE OF INTENSIVE IMMUNOSUPPRESSION TO ARREST NEUROLOGIC PROGRESSION [J].
NAIDU, S ;
BRESNAN, MJ ;
GRIFFIN, D ;
OTOOLE, S ;
MOSER, HW .
ARCHIVES OF NEUROLOGY, 1988, 45 (08) :846-848
[53]   Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy [J].
Netik, A ;
Forss-Petter, S ;
Holzinger, A ;
Molzer, B ;
Unterrainer, G ;
Berger, J .
HUMAN MOLECULAR GENETICS, 1999, 8 (05) :907-913
[54]   VERY LONG-CHAIN FATTY-ACIDS IN X-LINKED ADRENOLEUKODYSTROPHY BRAIN AFTER TREATMENT WITH LORENZOS OIL [J].
POULOS, A ;
GIBSON, R ;
SHARP, P ;
BECKMAN, K ;
GRATTANSMITH, P .
ANNALS OF NEUROLOGY, 1994, 36 (05) :741-746
[55]   Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy [J].
Pouwels, PJW ;
Kruse, B ;
Korenke, GC ;
Mao, X ;
Hanefeld, FA ;
Frahm, J .
NEUROPEDIATRICS, 1998, 29 (05) :254-264
[56]   THE INFLAMMATORY MYELINOPATHY OF ADRENOLEUKODYSTROPHY - CELLS, EFFECTOR MOLECULES, AND PATHOGENETIC IMPLICATIONS [J].
POWERS, JM ;
LIU, Y ;
MOSER, AB ;
MOSER, HW .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, 51 (06) :630-643
[57]   Adrenomyeloneuropathy: A neuropathologic review featuring its noninflammatory myelopathy [J].
Powers, JM ;
DeCiero, DP ;
Ito, M ;
Moser, AB ;
Moser, HW .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (02) :89-102
[58]   BRAIN, LIVER, AND ADIPOSE-TISSUE ERUCIC AND VERY LONG-CHAIN FATTY-ACID LEVELS IN ADRENOLEUKODYSTROPHY PATIENTS TREATED WITH GLYCERYL TRIERUCATE AND TRIOLEATE OILS (LORENZO-OIL) [J].
RASMUSSEN, M ;
MOSER, AB ;
BOREL, J ;
KHANGOORA, S ;
MOSER, HW .
NEUROCHEMICAL RESEARCH, 1994, 19 (08) :1073-1082
[59]   Neurophysiological abnormalities in adrenoleukodystrophy carriers - Evidence of different degrees of central nervous system involvement [J].
Restuccia, D ;
DiLazzaro, V ;
Valeriani, M ;
Oliviero, A ;
LePera, D ;
Colosimo, C ;
Burdi, N ;
Cappa, M ;
Bertini, E ;
DiBiase, A ;
Tonali, P .
BRAIN, 1997, 120 :1139-1148
[60]   DIETARY ERUCIC-ACID THERAPY FOR X-LINKED ADRENOLEUKODYSTROPHY [J].
RIZZO, WB ;
LESHNER, RT ;
ODONE, A ;
DAMMANN, AL ;
CRAFT, DA ;
JENSEN, ME ;
JENNINGS, SS ;
DAVIS, S ;
JAITLY, R ;
SGRO, JA .
NEUROLOGY, 1989, 39 (11) :1415-1422